Walgreen Reports Strong Topline Growth But Pharmacy Margin Pressure Remains

While Walgreen remains confident of seeing a continuing growth in its top line, it believes that the margin pressure will persist in the short-term. A cautious consumer, ongoing reimbursement pressure, generic drug inflation and significant step-downs from Med D reimbursement rates, are some of the factors that will act as headwinds in fiscal 2015.